161 related articles for article (PubMed ID: 8698526)
1. Chronic experimental Chagas' disease: functional syngeneic T-B-cell cooperation in vitro in the absence of an exogenous stimulus.
Freire-de-Lima C; Peçanha LM; Dos Reis GA
Infect Immun; 1996 Jul; 64(7):2861-6. PubMed ID: 8698526
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway.
Lopes MF; DosReis GA
Infect Immun; 1996 May; 64(5):1559-64. PubMed ID: 8613360
[TBL] [Abstract][Full Text] [Related]
3. Anti-Ia treatment modulates specific and polyclonal antibody responses in Trypanosoma cruzi-infected mice.
Spinella S; Liegeard P; Guilbert B; Hontebeyrie-Joskowicz M
J Autoimmun; 1989 Dec; 2(6):791-802. PubMed ID: 2515867
[TBL] [Abstract][Full Text] [Related]
4. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.
Marinho CR; D'Império Lima MR; Grisotto MG; Alvarez JM
Infect Immun; 1999 Jan; 67(1):308-18. PubMed ID: 9864231
[TBL] [Abstract][Full Text] [Related]
5. A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi.
Ribeiro-Dos-Santos R; Mengel JO; Postol E; Soares RA; Ferreira-Fernandez E; Soares MB; Pontes-De-Carvalho LC
Parasite Immunol; 2001 Feb; 23(2):93-101. PubMed ID: 11240900
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi.
dos Santos RR; Rossi MA; Laus JL; Silva JS; Savino W; Mengel J
J Exp Med; 1992 Jan; 175(1):29-39. PubMed ID: 1730921
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
[TBL] [Abstract][Full Text] [Related]
8. B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity.
Croft M; Swain SL
J Immunol; 1991 Dec; 147(11):3679-89. PubMed ID: 1682380
[TBL] [Abstract][Full Text] [Related]
9. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.
Rizzo LV; Cunha-Neto E; Teixeira AR
Infect Immun; 1989 Sep; 57(9):2640-4. PubMed ID: 2474498
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi.
Carlier Y; Rivera MT; Truyens C; Goldman M; Lambert P; Flament J; Bauwens D; Vray B
Infect Immun; 1987 Oct; 55(10):2496-501. PubMed ID: 3115899
[TBL] [Abstract][Full Text] [Related]
12. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
Lopes MF; da Veiga VF; Santos AR; Fonseca ME; DosReis GA
J Immunol; 1995 Jan; 154(2):744-52. PubMed ID: 7814881
[TBL] [Abstract][Full Text] [Related]
13. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
[TBL] [Abstract][Full Text] [Related]
14. Increased immunoglobulin secretion by B lymphocytes from Trypanosoma cruzi infected mice after B lymphocytes-natural killer cell interaction.
De Arruda Hinds LB; Alexandre-Moreira MS; Decoté-Ricardo D; Nunes MP; Peçanha LM
Parasite Immunol; 2001 Nov; 23(11):581-6. PubMed ID: 11703809
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
Gironès N; Cuervo H; Fresno M
Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
[TBL] [Abstract][Full Text] [Related]
16. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
[TBL] [Abstract][Full Text] [Related]
17. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock.
Jacobs F; Dubois C; Carlier Y; Goldman M
Clin Exp Immunol; 1996 Feb; 103(2):233-8. PubMed ID: 8565305
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
[TBL] [Abstract][Full Text] [Related]
19. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
20. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
